2Rodriguez-Bano,Navano MP,Romerol,et al.Epidemiology and clinical features of infection caused by extended spectrum beta-lactamase-producing Eschericlia coli in nonhospitalized patients[J].J Clin Microbiol,2004,42(9):4089-4094.
3Kar lowsky JA,Thomsberny C,Jones ME,et al.Susceptibility of antimicrobial -resistant urinary Eschericli coli isolates to fluroquinolones and nitrofurantoin[J].Clin Infect Dis,2003,36(1):183-187.
1[1]Gums JG.Assessing the impact of antimicrobial resistance[J].Am J Health Syst Pharm,2002,59(8 Suppl 3): S4-A6.
2[2]Iqbal M,Patel IK,Shah SH,et al.Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype[J].J Pak Med Assoc,2002,52(9): 407-411.
3[3]Karlowsky JA,Thornsberry C,Jones ME,et al.Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin[J].Clin Infect Dis,2003,36(2): 183-187.
4[4]Oteo J,Campos J,Baquero F,et al.Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001)[J].J Antimicrob Chemother,2002,50(6): 945-952.
5Welsh J,McClelland M.Fingerprinting genomes using PCR with arbitrary primers[J].Nucleic Acids Res,1990,18:7213 -7216.
6Williams JGK,Kubelik AR,Livak KJ,et al.DNA polymorphisms amplified by arbitrary primers are useful as genetic markers [J].Nucleic Acids Res,1990,18:6531-6534.
7Power EGM.RAPD typing in microbiology technical review[J].J Hosp Infect,1996,34:247.
8Eisen D,Russell ED,Tymms M,et al.Random amplified polymorphism DNA and plasmid analysis used in investigation of an outbreak of multi-resistant Klebsiella pneumonia [ J ].J Clin Microbial,1995:33:713.
9HAN SPEIJER,PAUL H.M.SAVELKOUL,MARC J.BONTEN,etc.Application of Different Genotyping Methods for pseudomonas aeruginosa in a Setting of Endemicity in an Intensive Care Unit[J].Journal of Clinical Microbiology,1999,37:3654-3661.
